about
Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up: a study from the population-based PROFILES registryInvestigating the performance and cost-effectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): protocol of a prospective multicenter cohort study in the NetherlTreatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians.Reproductive and hormonal factors in association with ovarian cancer in the Netherlands cohort study.Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysisDutch Translation and Psychometric Testing of the 9-Item Shared Decision Making Questionnaire (SDM-Q-9) and Shared Decision Making Questionnaire-Physician Version (SDM-Q-Doc) in Primary and Secondary CareTOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.Consecutive magnetic resonance imaging during brachytherapy for cervical carcinoma: predictive value of volume measurements with respect to persistent disease and prognosis.Sentinel node in ovarian cancer: study protocol for a phase 1 study.Is three-dimensional ultrasonography of additional value in the assessment of adnexal masses?Paper-Based Survivorship Care Plans May be Less Helpful for Cancer Patients Who Search for Disease-Related Information on the Internet: Results of the Registrationsystem Oncological Gynecology (ROGY) Care Randomized Trial.Understanding Lymphatic Drainage Pathways of the Ovaries to Predict Sites for Sentinel Nodes in Ovarian Cancer.External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancerCytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled studyMolecular biomarkers in cervical cancer diagnosis: a critical appraisal.Angiosarcomas of primary gynecologic origin: a clinicopathologic review and quantitative analysis of survival.The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3.Lymph-node metastasis in stage I and II sex cord stromal and malignant germ cell tumours of the ovary: a systematic review.Mucinous borderline tumours of the ovary and the appendix: a retrospective study and overview of the literature.Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subset.Natural history of high-grade cervical intraepithelial neoplasia: a review of prognostic biomarkers.Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis.Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients.Physicians' Awareness, Attitudes, and Experiences Regarding Imiquimod Treatment of Vaginal and Cervical Intraepithelial Neoplasia.Survivorship Care Plans to inform the primary care physician: results from the ROGY care pragmatic cluster randomized controlled trial.A family history questionnaire improves detection of women at risk for hereditary gynecologic cancer: a pilot study.Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer.Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol.The impact of lymph node dissection and adjuvant chemotherapy on survival: A nationwide cohort study of patients with clinical early-stage ovarian cancer.The relation between age, time since menopause, and endometrial cancer in women with postmenopausal bleeding.Prediction of incomplete primary debulking surgery in patients with advanced ovarian cancer: An external validation study of three models using computed tomography.Surgery for Recurrent Epithelial Ovarian Cancer in the Netherlands: A Population-Based Cohort Study.ETN-1: a new human endometrial carcinoma cell line producing ascites and distant metastases in nude mice.Health-related quality of life in cervical cancer survivors: a population-based survey.The role of surgery in the management of patients with platinum-sensitive recurrent ovarian cancer: survey among Dutch gynecologists and medical oncologists.Does recruitment for multicenter clinical trials improve dissemination and timely implementation of their results? A survey study from the Netherlands.Oncology providers' evaluation of the use of an automatically generated cancer survivorship care plan: longitudinal results from the ROGY Care trial.The value of imaging of the lungs in the diagnostic workup of patients with endometrial cancer.Bipolar versus balloon endometrial ablation in the office: a randomized controlled trial.Health related quality of life and symptoms after pelvic lymphadenectomy or radiotherapy vs. no adjuvant regional treatment in early-stage endometrial carcinoma: a large population-based study.
P50
Q28267883-42F9BB12-BFFE-4BB8-91CA-C8703AB019A8Q30407535-8A40580C-71B8-4277-A99E-6A493230076FQ34051920-5074EA01-A995-490E-AF30-A4D21CC95317Q34268606-29B023D6-856F-4009-8754-8E7E98F57D48Q34656453-D042F0F2-EAF7-41AD-956B-C49BC97BFAD0Q35685350-5667859C-8D35-4F6F-A7E7-AC8574285CB1Q35929418-881998B7-CCD4-469C-9A5F-15F2A3FAAF08Q36354267-3C1EE8DB-1BE4-45DC-AEEF-E45A4A66E068Q36624373-ED52361F-847F-42CE-8736-854C43824C03Q36817546-28378B68-6341-4094-B57D-886927CD8174Q37119931-12F047CD-7060-4EE7-AF2A-6EDF3241E726Q37409644-0B114598-BA93-4F7E-A75A-0C9A7A1F975DQ37459671-BF003263-5165-4CA1-9479-D14EB032159AQ37501224-2EFA106C-68B2-48B6-AAE7-ADF34D8F871AQ38115352-1ACD9038-40B7-42CB-A084-F07E3FCC477BQ38164532-E27B2C97-045F-45ED-9D3A-C81489866B93Q38179596-29DD0D60-D9A6-49CE-8A11-5BEEFDE4D4D9Q38179805-23DB4324-8283-4BF7-BCF9-1698CF1D561DQ38189520-9239452B-7962-4D65-8176-1E84C06E4DC0Q38253148-03E2A33F-FB38-411E-B0D7-DEB23210209BQ38363737-D98DF292-62AF-46AC-AF62-6FACF82FDBF4Q38752977-4A3A36E5-1DE2-4329-92B5-06C517991660Q38759550-28859EB4-AAEE-4EB1-BF99-97ED5F777B26Q38941618-62872A9D-8E9B-4C00-B566-06F110A5AA68Q39185769-0F709EF0-E416-4992-8829-AA6E9BAA93A7Q39230258-724833C6-9FB6-4520-B22C-8DFBE76093B3Q39256449-D29DA69F-C31C-4898-A51E-5EA23DA0E339Q39390875-8D1B4FF8-A2F2-4E87-9736-83DF5232644DQ39478338-7B2B0A26-5CED-4935-95BB-29F0CF514F49Q40224692-76162688-5999-4540-B6FE-F474DDE6FB4BQ40274564-3AED45BE-B440-4FBE-A284-104CE3C8DCADQ40297286-7610A027-0BAC-48AC-B237-EB0A4F19F153Q41840039-D0F11A96-6F83-42B5-8CED-B56644108D47Q44584227-F49DEAC6-35D0-4014-92E7-B31AE0287564Q45192958-C076CA50-E9EF-448B-8D32-8B9686124425Q45394714-D2D5DFB6-364D-4589-BBD6-25E0E74F419DQ45900645-44BAD17B-ADCA-4523-83FF-1D315DFB7C14Q46897254-43E60FA4-F2F6-426C-AEB6-F2D99964715BQ47881169-C473A96D-66E7-4335-9AE6-03016B0E526DQ48427612-79AF04EB-53DE-4049-86D4-2C6CD3E20070
P50
description
researcher ORCID ID = 0000-0002-1305-9541
@en
wetenschapper
@nl
name
Roy F.P.M. Kruitwagen
@ast
Roy F.P.M. Kruitwagen
@en
Roy F.P.M. Kruitwagen
@es
Roy F.P.M. Kruitwagen
@nl
type
label
Roy F.P.M. Kruitwagen
@ast
Roy F.P.M. Kruitwagen
@en
Roy F.P.M. Kruitwagen
@es
Roy F.P.M. Kruitwagen
@nl
prefLabel
Roy F.P.M. Kruitwagen
@ast
Roy F.P.M. Kruitwagen
@en
Roy F.P.M. Kruitwagen
@es
Roy F.P.M. Kruitwagen
@nl
P106
P31
P496
0000-0002-1305-9541